Categories Cancer

Breakthroughs That Can Help Breast Cancer Patients Improve Quality Of Life

Breakthroughs That Can Help Breast Cancer Patients Improve Quality Of Life Oncologists are increasingly understanding that a one-size-fits-all approach is not the best way to treat breast cancer. Many factors play a role in selecting the best treatment path, including the disease stage, tumour biology and of course the patient’s preferences. Image: Shutterstock Another important […]

Read More
Categories Cancer

Study reveals why Black men with prostate cancer have greater survival benefits from …

Study reveals why Black men with prostate cancer have greater survival benefits from … Black men die more often of prostate cancer yet, paradoxically, have greater survival benefits from immunotherapy treatment. A new Northwestern Medicine study discovered the reason appears to be an increase of a surprising type of immune cell in the tumor. The […]

Read More
Categories Uncategorized

Actinium Announces Participation in BIO CEO & Investor Digital Conference

Actinium Announces Participation in BIO CEO & Investor Digital Conference NEW YORK, Feb. 10, 2021 /PRNewswire/ — Actinium Pharmaceuticals, Inc.  (NYSE AMERICAN: ATNM) (“Actinium” or the “Company”) today announced that management will participate in the BIO CEO & Investor conference, which is being held digitally February 16 – 18, 2021. Members of Actinium’s executive team […]

Read More
Categories Multiple Myeloma

FDA Clears Way for Clinical Trial of HDP-101

FDA Clears Way for Clinical Trial of HDP-101 Heidelberg Pharma has been cleared in the U.S. to begin a clinical trial testing its investigational therapy HDP-101 for the treatment of multiple myeloma. The U.S. Food and Drug Administration (FDA) allowed the start of a Phase 1/2a trial following the submission of an investigational new drug […]

Read More
Categories Multiple Myeloma

2018 Treatment Algorithm for Multiple Myeloma

2018 Treatment Algorithm for Multiple Myeloma Getting Clear Answers to Complex Treatment Challenges in Multiple Myeloma: Case Discussions 2018 Treatment Algorithm for Multiple Myeloma Presented by S. Vincent Rajkumar, MD Friday, December 8, 2017 Atlanta, Georgia Friday Satellite Symposium preceding the 59th ASH Annual Meeting & Exposition. This activity is supported by educational grants from […]

Read More
Categories Cancer

Rhizen’s cancer drug Umbralisib gets USFDA nod: Alembic Pharma – The Economic Times

Rhizen’s cancer drug Umbralisib gets USFDA nod: Alembic Pharma – The Economic Times Alembic Pharma on Tuesday said its associate company Rhizen Pharmaceuticals AG’s product Umbralisib, which was licensed to TG Therapeutics, has received approval from the US health regulator the drug for the treatment of certain forms of cancer. In a regulatory filing, Alembic […]

Read More
Categories Cancer

Alembic’s affiliate Rhizen bags US regulator nod for oral cancer drug

Alembic’s affiliate Rhizen bags US regulator nod for oral cancer drug In what could further boost Alembic Pharmaceutical’s oncology business, its co-owned clinical-stage biopharmaceutical firm Rhizen Pharmaceuticals AG has bagged US Food and Drug Administration (USFDA) nod for an oral drug indicated in treating lymphoma. Umbralisib is indicated for treatment of adult patients with relapsed […]

Read More
Categories Cancer

Two-year-old girl, diagnosed with a rare type of cancer, gets successfully treated in Chennai hospital

Two-year-old girl, diagnosed with a rare type of cancer, gets successfully treated in Chennai hospital CHENNAI: Doctors at the Gleneagles Global Health City in Chennai successfully treated a 2-year-old from Assam, who was detected with a lesion in her mouth last year in April.  According to a statement from the hospital, even though the lesion […]

Read More
Categories Cancer

Orion and Bayer expand development program for darolutamide in prostate cancer

Orion and Bayer expand development program for darolutamide in prostate cancer ORION CORPORATION PRESS RELEASE 8 FEBRUARY 2021 at 14.00 EET                       Orion and Bayer expand development program for darolutamide in prostate cancer Phase III study ARANOTE to be initiated in metastatic hormone-sensitive prostate cancer (mHSPC) assessing the novel androgen-receptor antagonist in combination with standard […]

Read More
Categories Cancer

Hologic taps Google Cloud for AI-driven cervical cancer screening collaboration

Hologic taps Google Cloud for AI-driven cervical cancer screening collaboration Hologic has tapped Google Cloud to help elevate its digital pathology platforms for diagnosing cervical cancer with new artificial intelligence and machine learning programs. The medtech’s Genius cytology system digitally stacks 2D images of a patient’s cells to provide additional visual depth to glass Pap […]

Read More